21628662

Source:http://linkedlifedata.com/resource/pubmed/id/21628662

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017431, umls-concept:C0019196, umls-concept:C0021747, umls-concept:C0030705, umls-concept:C0035525, umls-concept:C0087111, umls-concept:C0205174, umls-concept:C0681890, umls-concept:C0871261, umls-concept:C1416514, umls-concept:C1425475, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C1876229, umls-concept:C1882417, umls-concept:C2911692
pubmed:issue	1
pubmed:dateCreated	2011-6-1
pubmed:abstractText	Pegylated interferon, ribavirin, and telaprevir triple therapy is a new strategy expected to eradicate the hepatitis C virus (HCV) even in patients infected with difficult-to-treat genotype 1 strains, although adverse effects, such as anemia and rash, are frequent.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0413675
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/IL28B protein, human, http://linkedlifedata.com/resource/pubmed/chemical/ITPA protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Interferons, http://linkedlifedata.com/resource/pubmed/chemical/Interleukins, http://linkedlifedata.com/resource/pubmed/chemical/NS-5 protein, hepatitis C virus, http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides, http://linkedlifedata.com/resource/pubmed/chemical/Pyrophosphatases, http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin, http://linkedlifedata.com/resource/pubmed/chemical/Viral Core Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Viral Nonstructural Proteins, http://linkedlifedata.com/resource/pubmed/chemical/nucleocapsid protein, Hepatitis C..., http://linkedlifedata.com/resource/pubmed/chemical/telaprevir
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1537-6613
pubmed:author	pubmed-author:AbeHiromiH, pubmed-author:AkutaNorioN, pubmed-author:ChayamaKazuakiK, pubmed-author:HayesC NelsonCN, pubmed-author:KamataniNaoyukiN, pubmed-author:KarinoYoshiyasuY, pubmed-author:KobayashiMarikoM, pubmed-author:KumadaHiromitsuH, pubmed-author:MikiDaikiD, pubmed-author:NakamuraYusukeY, pubmed-author:OchiHidenoriH, pubmed-author:SezakiHitomiH, pubmed-author:SuzukiFumitakaF, pubmed-author:ToyotaJojiJ
pubmed:issnType	Electronic
pubmed:day	1
pubmed:volume	204
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	84-93
pubmed:dateRevised	2011-10-11
pubmed:meshHeading	pubmed-meshheading:21628662-Adult, pubmed-meshheading:21628662-Aged, pubmed-meshheading:21628662-Antiviral Agents, pubmed-meshheading:21628662-Female, pubmed-meshheading:21628662-Genotype, pubmed-meshheading:21628662-Hepatitis C, pubmed-meshheading:21628662-Humans, pubmed-meshheading:21628662-Interferons, pubmed-meshheading:21628662-Interleukins, pubmed-meshheading:21628662-Male, pubmed-meshheading:21628662-Middle Aged, pubmed-meshheading:21628662-Oligopeptides, pubmed-meshheading:21628662-Polymorphism, Genetic, pubmed-meshheading:21628662-Predictive Value of Tests, pubmed-meshheading:21628662-Pyrophosphatases, pubmed-meshheading:21628662-Ribavirin, pubmed-meshheading:21628662-Treatment Outcome, pubmed-meshheading:21628662-Viral Core Proteins, pubmed-meshheading:21628662-Viral Nonstructural Proteins
pubmed:year	2011
pubmed:articleTitle	IL28B but not ITPA polymorphism is predictive of response to pegylated interferon, ribavirin, and telaprevir triple therapy in patients with genotype 1 hepatitis C.
pubmed:affiliation	Laboratory for Digestive Diseases, Center for Genomic Medicine, RIKEN, Japan. chayama@hiroshima-u.ac.jp
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't